Torta R, Zanalda E
Istituto di Clinica Psichiatrica, Università di Torino.
Minerva Psichiatr. 1990 Jul-Sep;31(3):161-6.
On the basis of the psychosomatic model, an interpretation of hypnositherapy is proposed in the psychobiological context as an applicative example of oneness. With this technique a particular state of awareness, which hypnosis is, correlated biologically with considerable subcortical neurophysiological modifications in the individual, is added, as a facilitating context, into the activation of patients psychotherapy. Thereafter the neurophysiological characterisation of the hypnotic state such as activation of the right hemisphere, similarities between transhypnosis and synchronous sleep and the activation of subcortical mechanisms compared to the cortical are considered. In the hypnotic situation, two very special conditions which are extremely important in the biological context, operate: on the one hand the special physician/patient relationship, on the other the important psychosomatic implication deriving from the possibility of direct action on mesolimbic and hypothalamus following the reduced cortical activity. After examining the context of the physician/patient relationship in the clinical implication of the placebo, or non-pharmacological effect of the drug implied, the psychosomatic activation mechanisms that can be the reason for modifications in the symptom, including its improvement or actual cure are considered. In this context, the psychosomatic evaluational parameter inherent in cognitive evaluation to which the cortical filter is correlated, the emotional activation to which activation of the limbic system is correlated and, finally, the set of psychophysiological variations correlated to this limbic activation underlying behavioural and somatic modifications are reviewed.
基于心身模型,本文在心身生物学背景下提出了一种对催眠疗法的解释,将其作为整体性的一个应用实例。通过这种技术,一种特殊的意识状态,即催眠,在生物学上与个体相当大的皮质下神经生理变化相关联,并作为一种促进性背景,被添加到患者心理治疗的激活过程中。此后,将考虑催眠状态的神经生理学特征,如右半球的激活、催眠与同步睡眠之间的相似性以及与皮质相比皮质下机制的激活。在催眠情境中,有两个在生物学背景下极其重要的特殊条件在起作用:一方面是特殊的医患关系,另一方面是由于皮质活动减少后对中脑边缘系统和下丘脑直接作用的可能性而产生的重要心身影响。在研究了安慰剂的临床意义或所暗示药物的非药理学效应中的医患关系背景之后,将考虑可能导致症状改变(包括症状改善或实际治愈)的心身激活机制。在这种背景下,将回顾与皮质过滤器相关的认知评估中固有的心身评估参数、与边缘系统激活相关的情绪激活,以及最后与这种边缘激活相关的、构成行为和躯体改变基础的一系列心理生理变化。